Clorox (NYSE:CLX) beats Q4 estimates with revenue growth and cost savings but warns of FY26 challenges amid market volatility and adjusted inventory management by retailers.

Shares of Novavax are trading lower Friday morning. The stock appears to be caught in a downdraft affecting COVID-19 vaccine ...

A post-earnings surge in Meta Platforms Inc. META +11.7% Get Free Report and Microsoft Corp. MSFT +4.15% Get Free Report sent ...